Featured Research

from universities, journals, and other organizations

HIV-infected Have Thicker Carotid Artery Walls--Predictor Of Heart Attack & Stroke

Date:
March 19, 2004
Source:
University Of California - San Francisco
Summary:
Carotid artery intima-media thickness (IMT) -- a potent predictor of heart attack and stroke -- is significantly higher in HIV-infected patients compared to uninfected controls, according to study results from UCSF researchers.

With the advent of antiretroviral medication, HIV patients are living longer and facing yet another health challenge.

Carotid artery intima-media thickness (IMT) -- a potent predictor of heart attack and stroke -- is significantly higher in HIV-infected patients compared to uninfected controls, according to study results from UCSF researchers. In addition after one year of follow-up, carotid artery IMT progressed significantly faster in HIV-infected individuals.

"Our findings suggest that it would be reasonable to consider HIV infection a cardiac risk factor. Other risk factors, such as high cholesterol and high blood pressure need to be aggressively treated in HIV patients -- even it if means changes in their HIV medications." said the study's lead author, Priscilla Hsue, MD, assistant professor of medicine at UCSF.

The study, published in the April 6th issue of Circulation, found that HIV infection was an independent predictor of carotid artery IMT along with age, LDL-cholesterol levels, and cigarette smoking. Duration of protease inhibitor therapy was not associated with thicker carotid IMT.

Carotid IMT progression over one year was greater among the 121 HIV patients with follow-up measurements. IMT progression was associated with older age, Latino race, and a history of a low CD4 cell count.

In order to address cardiovascular issues in HIV patients, Hsue is opening one of the first cardiac sub-specialty clinics for HIV patients at the UCSF Positive Health Program based at San Francisco General Hospital Medical Center (SFGHMC).

"The greater rate of progression in arterial thickening among HIV patients is a cause for concern because it indicates that these patients could experience more vascular events in the future. Our primary motivation for starting a cardiac specialty clinic was to address cardiac issues and risk factors in HIV patients and to try and prevent cardiac complications before they occur," said Hsue.

Study co-authors are Joan C. Lo, MD, UCSF assistant adjunct professor of medicine at the General Clinical Research Center; Arlana Franklin, RDMS, UCSF senior technologist; Ann F. Bolger, MD, UCSF associate professor of clinical medicine; Steven G. Deeks, MD, UCSF associate professor of clinical medicine at the Positive Health Program; and David D. Waters, MD, UCSF professor of medicine, all at SFGHMC; and Jeffrey N. Martin, MD, MPH, UCSF assistant professor in the Department of Epidemiology and Biostatistics.

The study was conducted at the General Clinical Research Center at SFGHMC. It was funded by grants from the Doris Duke Charitable Foundation, the National Institutes of Health, the California AIDS Research Center, the UCSF Academic Senate, the UCSF/Gladstone Institute for Virology and Immunology Center for AIDS Research, and Astra Zeneca.


Story Source:

The above story is based on materials provided by University Of California - San Francisco. Note: Materials may be edited for content and length.


Cite This Page:

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins